These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Verbal and visual memory in patients with early Parkinson's disease: effect of levodopa. Singh S; Behari M Neurol India; 2006 Mar; 54(1):33-7. PubMed ID: 16679640 [TBL] [Abstract][Full Text] [Related]
4. [Deficit of explicit memory in Parkinson's disease demonstrated by auditory-verbal and visual-design learning tasks]. Maruyama T Nihon Rinsho; 1997 Jan; 55(1):195-201. PubMed ID: 9014449 [TBL] [Abstract][Full Text] [Related]
5. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Pillon B; Dubois B; Bonnet AM; Esteguy M; Guimaraes J; Vigouret JM; Lhermitte F; Agid Y Neurology; 1989 Jun; 39(6):762-8. PubMed ID: 2725868 [TBL] [Abstract][Full Text] [Related]
6. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Cooper JA; Sagar HJ; Doherty SM; Jordan N; Tidswell P; Sullivan EV Brain; 1992 Dec; 115 ( Pt 6)():1701-25. PubMed ID: 1486457 [TBL] [Abstract][Full Text] [Related]
7. Spatial and non-spatial working memory at different stages of Parkinson's disease. Owen AM; Iddon JL; Hodges JR; Summers BA; Robbins TW Neuropsychologia; 1997 Apr; 35(4):519-32. PubMed ID: 9106280 [TBL] [Abstract][Full Text] [Related]
8. Levodopa's awakening effect on patients with Parkinsonism. Marsh GG; Markham CM; Ansel R J Neurol Neurosurg Psychiatry; 1971 Jun; 34(3):209-18. PubMed ID: 4398342 [TBL] [Abstract][Full Text] [Related]
9. Short-term memory in Parkinson's disease after withdrawal of long-term anticholinergic therapy. van Herwaarden G; Berger HJ; Horstink MW Clin Neuropharmacol; 1993 Oct; 16(5):438-43. PubMed ID: 8221704 [TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease affects automatic and spares intentional verbal learning. A stochastic approach to explicit learning processes. Faglioni P; Scarpa M; Botti C; Ferrari V Cortex; 1995 Dec; 31(4):597-617. PubMed ID: 8750021 [TBL] [Abstract][Full Text] [Related]
11. High-speed memory scanning in Parkinson's disease: adverse effects of levodopa. Poewe W; Berger W; Benke T; Schelosky L Ann Neurol; 1991 Jun; 29(6):670-3. PubMed ID: 1892368 [TBL] [Abstract][Full Text] [Related]
12. Effects of levodopa therapy in Parkinson's disease. II. Measurement of behavioural changes. Radbill R; Rosenberg G; Schwartz A Can Med Assoc J; 1974 Dec; 111(11):1218-22. PubMed ID: 4434291 [TBL] [Abstract][Full Text] [Related]
13. Memory for spatial location is affected in Parkinson's disease. Pillon B; Ertle S; Deweer B; Sarazin M; Agid Y; Dubois B Neuropsychologia; 1996 Jan; 34(1):77-85. PubMed ID: 8852695 [TBL] [Abstract][Full Text] [Related]
14. Effects of levodopa on corticostriatal circuits supporting working memory in Parkinson's disease. Simioni AC; Dagher A; Fellows LK Cortex; 2017 Aug; 93():193-205. PubMed ID: 28675834 [TBL] [Abstract][Full Text] [Related]
15. Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication. Cooper JA; Sagar HJ; Sullivan EV Neuropsychologia; 1993 Sep; 31(9):933-49. PubMed ID: 8232850 [TBL] [Abstract][Full Text] [Related]
16. Effects of Parkinson's disease and dopamine on digit span measures of working memory. Grogan JP; Knight LE; Smith L; Irigoras Izagirre N; Howat A; Knight BE; Bickerton A; Isotalus HK; Coulthard EJ Psychopharmacology (Berl); 2018 Dec; 235(12):3443-3450. PubMed ID: 30315362 [TBL] [Abstract][Full Text] [Related]
17. Perception and memory for faces in Parkinson's disease. Dewick HC; Hanley JR; Davies AD; Playfer J; Turnbull C Neuropsychologia; 1991; 29(8):785-802. PubMed ID: 1944878 [TBL] [Abstract][Full Text] [Related]
18. Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources. Cooper JA; Sagar HJ J Clin Exp Neuropsychol; 1993 Sep; 15(5):713-31. PubMed ID: 8276931 [TBL] [Abstract][Full Text] [Related]
19. Subtypes of Parkinson's disease defined by intellectual impairment. Mortimer JA; Jun SP; Kuskowski MA; Webster DD J Neural Transm Suppl; 1987; 24():101-4. PubMed ID: 3479520 [TBL] [Abstract][Full Text] [Related]
20. Levodopa and psychometric test performance in parkinsonism-5 years later. Riklan M; Whelihan W; Cullinan T Neurology; 1976 Feb; 26(2):173-9. PubMed ID: 814483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]